| HCAT |
Health Catalyst, Inc. |
Common Stock, $0.01 par value |
20% |
$41,210,964 |
-$137,918 |
13,922,623 |
-0.33% |
Mathew P. Arens |
01 Dec 2025 |
| PHLT |
Performant Healthcare, Inc. |
Common Stock, $0.01 par value |
16% |
$53,117,291 |
|
12,923,915 |
|
Mathew P. Arens |
30 Jun 2025 |
| MASS |
908 Devices Inc. |
Common Stock, $0.001 par value |
13% |
$27,617,068 |
+$6,599,752 |
4,680,859 |
+31% |
First Light Asset Management, LLC |
30 Nov 2025 |
| AXGN |
Axogen, Inc. |
Common Stock, $0.01 par value |
13% |
$105,980,875 |
+$23,458,744 |
5,940,632 |
+28% |
Mathew P. Arens |
30 Sep 2025 |
| SIBN |
SI-BONE, Inc. |
Common Stock, $0.001 par value |
12% |
$93,070,224 |
|
5,170,568 |
|
Mathew P. Arens |
30 Nov 2025 |
| KRMD |
KORU Medical Systems, Inc. |
Common Stock, $0.01 par value |
10% |
$12,012,641 |
+$627,617 |
4,824,354 |
+5.5% |
Mathew P. Arens |
30 Apr 2025 |
| NEO |
Neogenomics, Inc. |
Common Stock, $0.01 par value |
7.6% |
$73,287,770 |
|
9,784,749 |
|
Mathew P. Arens |
30 Jun 2025 |
| ORGO |
Organogenesis Holdings, Inc. |
Common Stock, $0.01 par value |
6.6% |
$35,730,437 |
|
8,309,404 |
|
Mathew P. Arens |
30 Jun 2025 |
| ANAB |
AnaptysBio Inc. |
Common Stock, $0.01 par value |
3.1% |
$26,474,603 |
-$42,907,347 |
864,618 |
-62% |
Mathew P. Arens |
30 Sep 2025 |
| FNA |
Paragon 28, Inc. |
Common Stock, $0.01 par value |
1.7% |
$18,718,661 |
-$119,897,999 |
1,429,997 |
-86% |
Mathew P. Arens |
28 Feb 2025 |
| OPRX |
OptimizeRx Corporation |
Common Stock, $0.01 par value |
0% |
$0 |
|
0 |
|
First Light Asset Management, LLC |
31 Dec 2024 |